Who invested in Beam Therapeutics?
Beam Therapeutics's investors include ARCH Venture Partners, F-Prime Capital, Redmile Group, Omega Funds and Google Ventures, and 7 more on record.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$322Mraised across 3 rounds since 2018, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recorded
Reported by FinSMEsSEC filing: $84M sold, first sale Feb 2018
Reported by FinSMEsSEC filing: $45M sold, first sale Feb 2018
From Beam Therapeutics's own website and the SEC filings it signed: 8 on the team.
On the board, as filediCarole HoKristina BurowMark FishmanMichael YiRobert NelsenStephen Knight
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Beam Therapeutics's investors include ARCH Venture Partners, F-Prime Capital, Redmile Group, Omega Funds and Google Ventures, and 7 more on record.
Beam Therapeutics has raised $322M across 3 rounds since 2018.
Beam Therapeutics's most recent round was a Debt of $100M in Feb 2026.
Beam Therapeutics's largest round on record is $135M (Series B), in Mar 2019.
Beam Therapeutics's first round on record, in May 2018, was backed by ARCH Venture Partners and F-Prime Capital.
Beam Therapeutics's latest named round is a Debt, in Feb 2026.
Beam Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.